Kuerten, Stefanie
Jackson, Leila J.
Kaye, Joel
Vollmer, Timothy L. http://orcid.org/0000-0002-1539-9830
Funding for this research was provided by:
Teva Pharmaceutical Industries, Frazer, PA (none)
Article History
First Online: 12 October 2018
Compliance with Ethical Standards
:
: SK has received research funding and payment for lectures from Teva Pharmaceutical Industries. LJJ was an employee of Teva Pharmaceutical Industries at the time the manuscript was written and held equity in the company. JK is an employee of Teva Pharmaceutical Industries. TLV has received payment for activities such as advisory boards, lectures, and consultancy from Academic CME, Alcimed, Anthem Blue Cross, Genentech/Roche, Biogen IDEC, Novartis, CellGene, Serono, Epigene, Rocky Mountain MS Center, GLG Consulting, Ohio Health, TG Therapeutics, Topaz Therapeutics, Dleara Lawyers, and Teva Neuroscience; he has also received research support from Teva Neuroscience, NIH/NINDS (National Institutes of Health/National Institute of Neurological Disorders and Stroke), Rocky Mountain MS Center, Biogen, Actelion, Genentech/Roche, UT Southwestern, F. Hoffman–La Roche Ltd., and TG Therapeutics Ltd.
: Editorial support and open-access fees were funded by Teva Pharmaceutical Industries, Frazer, PA, USA.